Last reviewed · How we verify
NCT06862843: DIETA-MICIREUM
Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-mediated Inflammatory Pathology. Observational Multicenter Study.
trial testing Collecting questionnaires and biological samples in Juvenile Idiopathic Arthritis (JIA) in 90 participants. Currently enrolling.
15 May 2025
Quick facts
| Lead sponsor | Meyer Children's Hospital IRCCS |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 90 |
| Start date | 7 February 2024 |
| Primary completion | 15 May 2025 |
| Estimated completion | 15 November 2025 |
| Sites | 4 locations across Italy |
Drugs / interventions tested
- Collecting questionnaires and biological samples
Conditions studied
- Juvenile Idiopathic Arthritis (JIA) — all drugs for Juvenile Idiopathic Arthritis (JIA) →
- Crohn Disease (CD) — all drugs for Crohn Disease (CD) →
- Ulcerative Colitis (UC) — all drugs for Ulcerative Colitis (UC) →
Sponsor
Meyer Children's Hospital IRCCS
Who can join
Eligibility, any sex, with Juvenile Idiopathic Arthritis (JIA) or Crohn Disease (CD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The proposed study is part of a PNRR 2022 project (call "Non-Communicable Chronic Diseases (NCDs) with high impact on healthcare and social assistance systems," currently awaiting funding response) and represents the continuation of an observational clinical study named TRANSMIC, approved by the pediatric ethics committee of the Tuscany region. TRANSMIC was an integral part of a European research project within the joint programming initiative (JPI), under the HDHL-INTIMIC theme: "A Healthy Diet for a Healthy Life," aimed at understanding the cause-effect relationships between diet, gut microbiome, and human health. Understanding the role of diet in inflammatory bowel diseases (IBD) and exploring its role in autoimmune inflammatory conditions with joint manifestations, such as JIA, provides additional insights into the development, progression, and management of these conditions, opening new horizons for the use of dietary treatments in preventing these inflammatory conditions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06862843
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Juvenile Idiopathic Arthritis (JIA)
Currently open trials in the same condition.
- NCT07087912 — Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases · Phase 4 · recruiting
- NCT07185750 — Investigation of Catastrophizing of Pain Reported by Parents in JIA Patients · recruiting
- NCT07234747 — Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic Arthritis · NA · recruiting
- NCT06806774 — Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopa · recruiting
- NCT06874608 — Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis · NA · recruiting
Other Meyer Children's Hospital IRCCS trials
Trials by the same sponsor.
- NCT07412782 — REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD) · NA · recruiting
- NCT07363304 — Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People Wi · recruiting
- NCT07412769 — ASMact: Study on Management of Bronchial Asthma · recruiting
- NCT07468461 — CACP: Study on Camptodactyly - Arthropathy - Coxa Vara - Pericarditis (CACP) Syndrome · recruiting
- NCT07348263 — EFESO: Study on Juvenile Onset Eosinophilic Fasciitis · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06862843 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Meyer Children's Hospital IRCCS
- Last refreshed: 6 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06862843.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing